These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10836735)

  • 1. Synthesis of 4,6-dichloro-3-[(1-N-arylaminocarbonyl)-hydrazono]-1,3-dihydro-indole-2 -one as a potential NMDA receptor glycine site antagonist.
    Hwang KJ; Lee TS
    Arch Pharm Res; 2000 Apr; 23(2):112-5. PubMed ID: 10836735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
    Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
    J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of tricyclic indole-2-carboxylic [correction of caboxylic] acids as potent NMDA-glycine antagonists.
    Katayama S; Ae N; Nagata R
    J Org Chem; 2001 May; 66(10):3474-83. PubMed ID: 11348132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 7,8-dichloro-6-nitro-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione as a potential NMDA receptor glycine site antagonist.
    Hwang KJ
    Arch Pharm Res; 2000 Feb; 23(1):31-4. PubMed ID: 10728653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological properties of novel glycine antagonists.
    Donati D; Di Fabio R
    Pharm Acta Helv; 2000 Mar; 74(2-3):239-45. PubMed ID: 10812964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affinity.
    Jansen M; Dannhardt G
    Eur J Med Chem; 2003 Oct; 38(10):855-65. PubMed ID: 14575932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
    Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
    J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antifungal evaluation of some 3-phenyl-2,5-disubstituted indoles derived from new ethyl-2-benzyl-2-[N-(aryl)hydrazono] ethanoates.
    Ergenç N; Salman A; Gürsoy A; Bankaoğlu G
    Pharmazie; 1990 May; 45(5):346-7. PubMed ID: 2395897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some 3-hydrazono-2-indolinones and N-Mannich bases as potential anticonvulsants.
    Gürsoy A; Karali N; Büyüktimkin S; Demirayak S; Ekinci AC; Ozer H
    Farmaco; 1996 Jun; 51(6):437-42. PubMed ID: 8766228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Gere A; Agai-Csongor E; Agai B; Tárkányi G; Horváth C; Barta-Szalai G; Bozó E; Kiss C; Bielik A; Nagy J; Farkas S; Domány G
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3859-61. PubMed ID: 14552795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New synthesis of substituted 2-carboxyindole derivatives: versatile introduction of a carbamoylethynyl moiety at the C-3 position.
    Hewkin CT; Di Fabio R; Conti N; Cugola A; Gastaldi P; Micheli F; Quaglia AM
    Arch Pharm (Weinheim); 1999 Feb; 332(2):55-8. PubMed ID: 10191715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
    Karcz-Kubicha M; Lorenz B; Danysz W
    Neuropharmacology; 1999 Jan; 38(1):109-19. PubMed ID: 10193902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Carling RW; Leeson PD; Moore KW; Smith JD; Moyes CR; Mawer IM; Thomas S; Chan T; Baker R; Foster AC
    J Med Chem; 1993 Oct; 36(22):3397-408. PubMed ID: 8230130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor.
    Gray NM; Dappen MS; Cheng BK; Cordi AA; Biesterfeldt JP; Hood WF; Monahan JB
    J Med Chem; 1991 Apr; 34(4):1283-92. PubMed ID: 1849994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P; Franks NP; Dickinson R
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
    Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
    Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
    Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
    Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.